Modulation of insulin degrading enzyme activity and liver cell proliferation.
Cell Cycle
; 14(14): 2293-300, 2015.
Article
en En
| MEDLINE
| ID: mdl-25945652
Palabras clave
CCNG2, Cyclin G2 gene, CDKN1A/P21, Cyclin-dependent kinase inhibitor 1A (p21, Cip1) gene; CDKN1B/P27, Cyclin-dependent kinase inhibitor 1B (p27, Kip1) gene; FAS, Fas cell surface death receptor gene; FBS, Fetal bovine serum; IDE, Insulin-degrading enzyme; MCM2, Minichromosome maintenance complex component 2 gene; MKI67, Marker of proliferation Ki-67 gene; NAFLD, Non-alcoholic fatty liver disease; NAS, Non-alcoholic fatty liver disease score; OGTT, Oral glucose tolerance test; PCNA, Proliferating cell nuclear antigen gene; SESN1, Sestrin 1 gene; T2DM, Type 2 diabetes mellitus.; TP53, Tumor protein p53 gene; TP53I3, Tumor protein p53 inducible protein 3 gene; hepatocellular carcinoma; insulin-degrading enzyme; non-alcoholic fatty liver disease; proliferation; qRT-PCR, Quantitative real-time PCR; type 2 diabetes mellitus
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Contexto en salud:
6_ODS3_enfermedades_notrasmisibles
Problema de salud:
6_endocrine_disorders
Asunto principal:
Proliferación Celular
/
Insulina
/
Insulisina
/
Hígado
Tipo de estudio:
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Risk_factors_studies
Límite:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Cell Cycle
Año:
2015
Tipo del documento:
Article
País de afiliación:
Alemania